脉压和新出现心房的风险
Gary F Mitchell1, Ramachandran S Vasan, Michelle J Keyes
1Cardiovascular Engineering Inc, Waltham, Mass 02453, USA. garyfmitchell@mindspring.com
JAMA
|February 22, 2007
概括
脉冲压的增加,这是对大动脉硬性的衡量标准,是发展心房动 (AF) 的重要危险因素. 这一发现强调了脉冲压作为预防AF发病率的目标.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 血管医学 血管医学
背景情况:
- 心房动 (AF) 对患病率和死亡率做出了重大贡献.
- 确定可修改的AF风险因素是公共卫生优先事项.
- 脉压增加,反映出大动脉硬,增加心脏负荷,并可能增加AF风险.
研究的目的:
- 为了研究脉冲压与心房的发生率之间的关系.
- 要确定脉冲压是否是AF的独立风险因素.
主要方法:
- 未来的,基于社区的观察性队列研究.
- 包括来自弗雷明汉心脏研究的5331名参与者,年龄在35岁以上,最初没有AF.
- 随访参与者的中位数为12年,以评估事件AF.
主要成果:
- 较高的脉压与显著增加发展AF的风险有关.
- 对AF的调整后危险比为1.26每20mm Hg脉冲压的增加 (P<.001).
- 平均动脉压与发生的AF无关,支持特定的脉冲压力效应.
结论:
- 脉压被确定为一般人群中发生性AF的重要风险因素.
- 进一步的研究是有必要的,以探索针对减轻脉冲压的干预措施,以预防AF.
相关概念视频
Heart Failure Drugs: β-Blockers
2.9K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.9K
Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Heart Failure I: Introduction
2.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2.0K
Heart Failure II: Pathophysiology
2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K


